Prosecution Insights
Last updated: April 19, 2026
Application No. 18/152,116

COMPOSITIONS AND METHODS USING SAME FOR SILICON CONTAINING FILMS

Non-Final OA §103§112
Filed
Jan 09, 2023
Examiner
ROLLAND, ALEX A
Art Unit
1759
Tech Center
1700 — Chemical & Materials Engineering
Assignee
VERSUM MATERIALS US, LLC
OA Round
3 (Non-Final)
46%
Grant Probability
Moderate
3-4
OA Rounds
3y 7m
To Grant
74%
With Interview

Examiner Intelligence

Grants 46% of resolved cases
46%
Career Allow Rate
271 granted / 585 resolved
-18.7% vs TC avg
Strong +27% interview lift
Without
With
+27.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
53 currently pending
Career history
638
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
61.4%
+21.4% vs TC avg
§102
12.3%
-27.7% vs TC avg
§112
24.1%
-15.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 585 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 7/10/25 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claim 6 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Claim 5 has been amended to require hydrogen plasma. This has caused a discrepancy in claim 6 that lists options without hydrogen plasma. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 5-7 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 2005/0025885 to McSwiney in view of US 2014/0273531 to Niskanen. McSwiney teaches a process for silicon nitride film formation using a silicon source precursor [0019]. The precursor is represented by the general formula in [0037-0041] and representative compounds are shown in Fig. 5. The following figure is the closest to claimed Formula I: PNG media_image1.png 181 217 media_image1.png Greyscale where R1 is a propyl (C3) group. McSwiney does not anticipate the claimed silazane precursor because the above figure lacks halide groups and R1 must be a methyl or ethyl group. However, from the general formula it is shown that any of the R groups (methyl in the figure) can be replaced with halogen [0037, 0039]. A replacement of at least 4 methyl groups with a halogen results in the claimed formula I. McSwiney goes on to explain the motivation for substituting in halogen [0036; 0052]. Specifically, the halogen causes Si-N bond strain, which leads to the desired lower silicon nitride formation temperature. Additionally, the difference between an R1 propyl group vs. methyl or ethyl group represents a homolog that differs by only one or two CH2 groups. Such very close structural similarity renders obvious the claimed composition due to the expectation that the compositions would have similar properties. McSwiney does not explicitly teach PEALD, although CVD, PECVD, and ALD are generally taught [0016]. However, Niskanen teaches a method of PEALD as an alternative to thermal ALD for depositing silicon nitride thin films [0024]. The PEALD process includes supplying the precursors sequentially separated by purging [0026] into a heated reactor [0059]. The precursors include a silicon precursor [0033], followed by a second reactant such as a plasma of hydrogen, He, or Ar [0034]. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to practice the method of McSwiney and substitute the ALD process with PEALD as described by Niskanen. This substitution amounts to the use of a known process for its intended purpose in a known environment to accomplish an expected result. Allowable Subject Matter Claims 1-4 are allowed. The following is a statement of reasons for the indication of allowable subject matter: Claims 1-4 have been amended to require heating the substrate to a temperature from 600-850°C. McSwiney is considered to be the closest prior art and only teaches reaction temperatures up to 550°C. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEX A ROLLAND whose telephone number is (571)270-5355. The examiner can normally be reached M-F 10-6:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Curtis Mayes can be reached on 5712721234. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALEX A ROLLAND/Primary Examiner, Art Unit 1759
Read full office action

Prosecution Timeline

Jan 09, 2023
Application Filed
Jul 19, 2024
Non-Final Rejection — §103, §112
Dec 23, 2024
Response Filed
Mar 06, 2025
Final Rejection — §103, §112
Jul 10, 2025
Request for Continued Examination
Jul 14, 2025
Response after Non-Final Action
Oct 17, 2025
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594529
PREPARATION METHOD OF TI3C2TX MXENE QUANTUM DOT (MQD)-MODIFIED POLYAMIDE (PA) REVERSE-OSMOSIS (RO) MEMBRANE
2y 5m to grant Granted Apr 07, 2026
Patent 12595622
Fabric Substrate and Manufacturing Method Thereof
2y 5m to grant Granted Apr 07, 2026
Patent 12589390
DETECTION CHIP AND MODIFICATION METHOD THEREFOR
2y 5m to grant Granted Mar 31, 2026
Patent 12586764
PLASMA SHOWERHEAD TREATMENT METHODS
2y 5m to grant Granted Mar 24, 2026
Patent 12577667
CYCLIC ALKYL AMINO CARBENE (CAAC) DEPOSITION BY TRANSMETALLATION
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
46%
Grant Probability
74%
With Interview (+27.4%)
3y 7m
Median Time to Grant
High
PTA Risk
Based on 585 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month